Fundraising FoxSR One Capital Management — 2020 Investments
6 investments dated 2020 · listed companies and verified rows first · show all
BiotechCambridge, US
Rick Lundberg(Executive Officer)George P. Vlasuk(Executive Officer, Director)in
BoardJean-Francois Formela(Director)inAlan Crane(Director)inMarian Nakada(Director)inBrian Gallagher(Director)in
Board seatRajeev Dadoo· per SEC Form D · $20.2M raise · filed May 2020
Co-investorsage1Brace PharmaSanofi VenturesAtlas VenturePolaris Partners
Palleon Pharma develops small molecule and biologic drugs targeting autoimmune and inflammatory diseases using proprietary glycoscience platforms.
BiotechDigital HealthMedical DevicesWaltham, US
Jim Broderick(Co-Founder)inJohn Hennessy(Executive Officer)Karen Hong(Director)James Lee(Director)Stephen Hoffman(Director)Li Peng(Chief Scientific Officer)
Board seatRajeev Dadoo· per SEC Form D
Co-investorsMatrix Capital ManagementPfizer VenturesPfizer Venture InvestmentsBioHealth Innovation, Inc.Takeda VenturesVertex Ventures HC
HotSpot Therapeutics develops novel biopharmaceutical products and therapeutic platforms focused on innovative biomedical technologies.
AI & Machine LearningBiotechHealthtech
BoardBruce Booth(Chairman)in
Co-investorsAtlas VentureB Capital GroupB4 CapitalMRL Ventures FundPivotal Life SciencesSofinnova Partners+2 more
.jpeg){kind=logo}
Co-investorsVivo CapitalRemiges Ventures, Inc.
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Entasis Therapeutics HoldingsDesign Therapeutics
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.